The impact of pre-existing HLA and red blood cell antibodies on transfusion support and engraftment in sickle cell disease after nonmyeloablative hematopoietic stem cell transplantation from HLA-matched sibling donors: A prospective, single-center, observational studyRobert Sheppard Nickel, Matthew M. Hsieh, Willy A. Flegel et al.|EClinicalMedicine|2020Cited by 20
Preventing transfusion‐associated graft‐versus‐host disease with blood component irradiation: indispensable guidance for a deadly disorderSorcha Ní Loingsigh, Christopher A. Tormey, Willy A. Flegel et al.|British Journal of Haematology|2020Cited by 14
Epidemiological and clinical features, therapeutic strategies and outcomes in patients with hyperhaemolysis: A systematic reviewJeremy W. Jacobs, Brian D. Adkins, Jennifer S. Woo et al.|British Journal of Haematology|2023Cited by 11
Highly efficient collection and manufacture of autologous HSC gene therapy cell product for patients with sickle cell disease using a lentiviral vector containing a shmir targeting BCL11aJohn Manis, David A. Williams, David G. Justus et al.|Blood|2025Cited by 1